Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Lack of functional CYLD in mice leads to early aging and cancer.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

YAP and TAZ proteins control skin cell growth and repair.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Topical JAK inhibitors may help treat hair loss.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Pexidartinib often causes liver issues and fatigue, especially in women.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

An arthritis drug helped a person with severe hair loss regrow their hair.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.